Key result
Beta blockers, statins, and aspirin are advocated to manage cardiac risk in patients undergoing non-cardiac surgery.
Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Such advocacy warrants caution in practice; leaves open need for definitive randomized trials.
Beta blocker, statin and aspirin advocated
No takes yet. Share an insight, caveat, or question.
Schouten et al. (2007) studied this question. Beta blockers, statins, and aspirin are advocated to manage cardiac risk in patients undergoing non-cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: